Stay updated with breaking news from Dermavant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Roivant Sciences Limited saw its shares rise after its subsidiary Dermavant Sciences reported positive topline results from ADORING 2, one of two Phase 3...
Results showed that Vtama cream 1% was safe, effective and well tolerated in a phase 3 study evaluating the cream in adults and children aged as young as 2 years with atopic dermatitis, Dermavant Sciences announced in a press release. “Ninety percent of the medicines that are addressing eczema in the United States are topical steroids,” Todd Zavodnick, CEO at Dermavant Sciences, told
15.03.2023 - 46.4% of subjects receiving VTAMA cream, 1% achieved the primary endpoint of Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-ADTM) response of clear (0) or almost clear (1) with at least a 2-grade improvement from baseline at ... Seite 1
Measles often starts behind the ears, and the eruption can look a lot like a drug eruption, says Dr Adelaide Hebert.
- ADORING 1 and 2 trials evaluating VTAMA cream in atopic dermatitis fully enrolled, with topline data expected from the first study in March 2023 and the second study in May 2023 - Dermavant recently